Selected Grants
Mallinckrodt MNK14344100: Phase 4 Multicenter randomized double blind placebo controlled pilot study to assess the efficacy and safety of H.P. Acthar Gel in subjects with Pulmonary Sarcoidosis
Clinical TrialPrincipal Investigator · Awarded by Mallinckrodt Pharmaceuticals · 2018 - 2023Prospective trial to validate safety of Hemolung Respiratory Assist System for COPD patients
Clinical TrialPrincipal Investigator · Awarded by ALung Technologies · 2018 - 2023Quantitative 129Xe Gas Exchange MRI for Idiopathic Pulmonary Fibrosis
Clinical TrialInvestigator · Awarded by Gilead Sciences, Inc. · 2015 - 2017CHEST ADVANCED CLINICAL TRAINING PROGRAM-Idiopathic Pulmonary Fibrosis
ConferencePrincipal Investigator · Awarded by American College of Chest Physicians · 2017 - 2017CHEST ADVANCED CLINICAL TRAINING PROGRAM-Idiopathic Pulmonary Fibrosis
ConferencePrincipal Investigator · Awarded by Chest Foundation · 2016 - 2016External Relationships
- Becton, Dickinson and Company
- Inspira
- Roche
- Select Medical
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.